Cara Therapeutics
+$0.23 (+2.87%) Today
+$0.26 (+3.16%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.
About CARA
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.
CEO
Christopher Posner
Employees
84
Headquarters
Stamford, Connecticut
Founded
2004
CARA Key Statistics
Market cap
441.59M
Price-Earnings ratio
—
Dividend yield
—
Average volume
556.45K
High today
$8.29
Low today
$7.89
Open price
$8.16
Volume
281.94K
52 Week high
$18.93
52 Week low
$7.40
CARA News
Analyst ratings
88%
of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
CARA Earnings
-$0.63
$0.11
$0.85
$1.59
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours